A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/555 (2006.01) A61K 31/513 (2006.01) A61K 31/519 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2606042
Methods of treating an oxaliplatin-sensitive cancer are disclosed in which a therapy comprising oxaliplatin is initiated, continued until a predetermined endpoint, stopped, then reintroduced after specific criteria are met. This stop-and-go approach reduces or eliminates the neurotoxicity associated with oxaliplatin administration while at the same increasing one or more of the beneficial effects of oxaliplatin therapy.
Robic
Sanofi-Aventis
LandOfFree
Stop-and-go oxaliplatin treatment regimens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stop-and-go oxaliplatin treatment regimens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stop-and-go oxaliplatin treatment regimens will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1908476